Our previous results pointed to a putative gene for susceptibility to bipolar affective disorder located on the chromosomal region 12q23-q24 that segregated in the Saguenay-Lac-St-Jean population of Quebec. We report here results from a second genome-wide scan based on the analysis of 380 polymorphic microsatellite markers. For the purpose of this analysis, an additional 18 families were recruited from the Saguenay-Lac-St-Jean region and pooled to our previous sample to improve its statistical power, giving a total of 394 sampled individuals. This work confirms the presence of a susceptibility locus for affective disorder on chromosome 12q24 with parametric LOD score value of 3.35 at D12S378 when pedigrees were broken into nuclear families and analysed under a recessive segregation model. This result was supported by neighbouring markers and by a LOD score value of 5.05 at D12S378 under model-free analysis. Other regions of lower interest were indicated on chromosomes 2, 5, 7, 9, 10, 17 and 20. Keywords: chromosome 12; complex disease; genome scan; linkage analysis; manic depression Bipolar disorder (also called manic depressive disorder) is a severe neuropsychiatric illness characterized by the occurrence of elevated mood (mania, hypomania) and depressive states. Lifetime prevalence for this disease was estimated from 0.4 to 1.6%; moreover, 15% of affected individuals commit suicide.
Bipolar disorder (also called manic depressive disorder) is a severe neuropsychiatric illness characterized by the occurrence of elevated mood (mania, hypomania) and depressive states. Lifetime prevalence for this disease was estimated from 0.4 to 1.6%; moreover, 15% of affected individuals commit suicide. 1 Twin, adoption and family studies have supported the importance of genetic factors in the predisposition to bipolar disorder but its aetiology remains unknown. Craddock and Jones 2 have reviewed proposed inheritance models. Delayed age of onset, imprecise definition of phenotype and oligogenic inheritance are all factors in bipolar disorder that complicate and reduce the power of linkage analysis. Until now, no chromosomal region has universal agreement for the presence of a vulnerability gene. Such results may be explained by the large sample size needed to replicate initial linkage finding for an oligogenic trait 3 and by the variability in location estimate, which may shift over substantial distances from the true disease locus. 4, 5 Despite these difficulties, some regions of interest were established such as 4p16, [6] [7] [8] [9] [10] 12q23-q24, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] 13q32-q33, 9, [21] [22] [23] [24] 18p11, [25] [26] [27] 18q21-q23, [28] [29] [30] 21q22 [31] [32] [33] [34] and Xq26. 35, 36 In order to reduce genetic heterogeneity in bipolar disorder, research groups have concentrated on isolated populations. Escamilla 37 reviews such studies performed on pedigrees sampled from Finland, Iceland, the Central Valley of Costa Rica, the Old Order Amish, Quebec and Scotland. Our previous results, based on a large kindred (called VL) sampled from the rather homogeneous population of the Saguenay-LacSt-Jean region of Eastern Quebec, pointed to a putative gene for bipolar affective disorder located on the long arm of chromosome 12. 16 Particularly, we reported two nonparametric multipoint peaks in genomic regions 12q21.33 and 12q24.23-qter. This result was supported by the analysis of an additional pedigree (called BM) coming from the same population and genotyped with chromosome 12 markers. Considering both families, a maximum parametric LOD score value of 2.87 was reported at D12S78 when pedigrees were broken into nuclear families and analysed under a recessive segregation model. However, a follow-up study did not support the presence of an expected founder effect for bipolar disorder in this population. 38 We now report results from a second genome-wide scan based on the analysis of 380 polymorphic microsatellite markers, 233 of which differed from markers previously used. 16 An additional 18 families were recruited from the Saguenay-Lac-St-Jean region and added to the BM and VL families to increase our statistical power to detect linkage and leading to a total of 394 sampled individuals. Since a similar extension of the original Old Order Amish pedigree led to loss of significant findings, the present addition of our original families could indicate the robustness of our results. This work confirms the presence of a susceptibility locus for affective disorder on chromosome 12q24 and also points to other regions of lower interest on chromosomes 2, 5, 7, 9, 10, 17 and 20.
Materials and methods

Ascertainment and diagnosis
Our diagnostic procedure has been described previously. 16 Briefly, probands were selected from 800 patients from L'Institut Roland Saucier on the basis of four criteria: (1) to have a diagnosis of bipolar I disorder (DSM-III-R); (2) to have a positive family history of bipolar disorder; (3) to be drawn from the Saguenay-Lac-St-Jean founder population; (4) to have a positive response to LiCO 3 . Their families were extended and recruited subjects were interviewed by using a French translation of the Structured Clinical Interview for DSM-IIIR (SCID I) 39 by psychiatric nurses or psychologists trained in its use. A bestestimate consensus diagnosis was established for each individual by a diagnostic panel that included at least two psychiatrists.
The whole sample contained 394 genotyped individuals from 20 families sampled from the Saguenay-Lac-St-Jean region, and 18 of these families had never before been included in linkage studies of bipolar disorder. The additional families, as do the original VL and BM families, have genealogies attached to the founding population of SaguenayLac-St-Jean but are not derived from a common ancestor couple. For the whole sample, diagnoses were distributed as follows: 77 bipolar type I (BPI), 28 bipolar type II (BPII), 43 recurrent major depressive disorder (UPR), 45 single-episode major depressive disorder (UPSE), 21 anxiety disorder, 35 alcohol/drug abuse, 12 diagnosis unknown and 133 normal. An unknown category was established for subjects whose status was unclear. The mean age at onset was 27.5871.30 years for BP cases and 28.8073.71 years for UPR cases.
Markers and genotyping
We genotyped 380 polymorphic microsatellite markers. 40 Data were stocked and managed from a 4D database (version 6.7.2) and were transferred from a Macintosh to a SUN Ultra 30 by using CAP (version 6.0) for linkage analysis. PEDCHECK program was used to identify genotyping inconsistencies. 41 Recombination fraction (y) between successive markers and allelic frequencies were estimated from our genotyping data with ILINK, from the FASTLINK package (version 4.0P) 42, 43 and the VITESSE algorithm 44 until convergence. The average intermarker distance, in terms of recombination fraction, was 0.099 with a maximal gap of 0.254 between loci D15S165 and D15S119. The mean of marker heterozygosity was 78%.
Linkage analysis
Definition of the affected category for linkage analysis is not obvious since affective disorders span a spectrum of associated states. Two hierarchical affection status models (ASMs) were used to define the affected phenotype. In the first model (ASMI), we considered individuals with diagnosis of BPI, schizoaffective disorder, bipolar type and BPII recurrent episode as affected, those with a diagnosis of single episode or recurrent episode major depression were classified as unknown status and all other diagnoses as unaffected. The second affection status model (ASMII) was the same as ASMI, but the affected category was extended to include individuals diagnosed with recurrent episode major depression. We used parametric and model-free statistical methods to analyse genotype data.
All computations were performed on a SUN ULTRA 30 workstation. Parametric analyses were performed with the ANALYZE package 45 on multiplex pedigrees and on their nuclear components since the sample contained large, densely affected kindred, which are more subject to intrafamily heterogeneity than are small ones. 46 The parametric LOD score values were calculated by using MLINK from FASTLINK package and were maximized over (y) varying from 0.0 to 0.5 by steps of 0.02. As proposed by Durner et al, 47 parametric linkage analysis was carried out under a simple dominant model and once under a simple recessive model with an arbitrary penetrance of 0.5. The disease allele frequency was fixed to 0.02 for the dominant model and 0.15 for the recessive model leading to a population prevalence of 1-2% with a phenocopy rate of less than 1% for both models.
In order to report the extent of excess of allele sharing identical-by-descent (IBD), pairwise modelfree analysis, based on affected-sib-pairs (ASPs), was carried out with the ANALYZE package. Sibships were weighted according to their size; only sÀ1 independent ASPs were used with s affected sibs. To increase the power of our sample, pairwise ASP analysis was carried out by considering all ASPs (s(sÀ1)/2 pairs) with the sib_ibd module from the ASPEX package (version 1.85, David Hinds and Neil Risch, 1999; ftp://lahmed.stanford.edu/pub/aspex). Sib_ibd uses sibships with unambiguous IBD status for calculation purpose, but it may reconstruct missing parent genotypes based on the offspring genotypes. As suggested by Hauser et al, 48 empirical P-values were established for the sib_ibd model-free LOD score since our sample contained densely affected sibships. For each locus where LOD score values greater than 1 were observed, we simulated the whole sample with SLINK 49 under the ASM that maximized LOD score by considering a marker with the same allelic frequencies and an unlinked putative susceptibility gene (y ¼ 0.5). Each sample replicate was analysed with sib_ibd and the P-value was estimated as the number of LOD score values, obtained by simulation, greater than the reported LOD score value divided by the number of simulations.
Although we were aware that the use of several analytical methods and ASM could increase the false positive rate, no correction was applied. Indeed, there was no clear way to establish the correct increase of false positives since tests were correlated. We believe that consistent linkage findings derived through different statistical approaches and replication of them from other independent groups represent the best criteria to assess result validity in complex disease analysis as highlighted by Detera-Wadleigh et al. 
Results
Parametric analysis
Loci with maximum LOD score value greater than 1 are shown in Table 1 . Under ASMII, with a recessive mode of transmission and with the pedigrees broken into nuclear families, six successive loci with maximum LOD score values greater than 2 were observed over a 20 Mb region on the long arm of chromosome 12. Particularly, we obtained maximal LOD score values greater than 3 at loci D12S366, D12S86 and D12S378. Two clusters of adjacent loci from chromosome 17 were above 1 as shown in Table 1 ; the maximal LOD score value of 2.56 was observed at locus D17S925. Other regions showed adjacent loci with maximum LOD score values greater than 1 but below 1.5: a first one on chromosome 9 (D9S171 and D9S161) and a second one on chromosome 20 (D20S119 and D20S100). Four isolated markers (D5S673, D6S264, D12S326 and DXS1106) gave maximal LOD score values greater than 1.50.
Model-free analysis
Results obtained from the sib_ibd module are shown in Table 2 . Model-free analysis confirmed an excess of allele sharing IBD by affected sib-pairs in the region situated between markers D12S326 and D12S1714. A maximal LOD score value of 5.05 (empirical P-value Marker band and position were from the UCSC genome browser (http://genome.ucsc.edu/). a Maximum LOD score observed when families were broken into nuclear families. Successive loci with maximum LOD score value 41 are grouped together.
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) was observed at D12S378 corresponding to a proportion of affected sibs sharing allele IBD of 67.5%. A maximum LOD score value of 3.46 (empirical P-values ¼ 0.002, IBD sharing ¼ 65.1) was obtained at D17S798, which was previously included in the cluster of four successive loci with parametric LOD score values greater than 1. Figure 1 shows the model-free multipoint analyses with sib_ibd over chromosomal regions 12q14.1-12q24.33 and 17p13.3-17q21.31 considering the whole sample and new families under ASMI and ASMII. We observed higher model-free LOD score values under ASMII compared to ASMI, which could be explained by a gain in power by including UPR as affected diagnosis. Maximum LOD scores values were still observed at D12S378 and D17S798. The 18 additional new pedigrees support linkage in these regions and, in particular, the prior evidence of linkage over the telomeric part of the long arm of chromosome 12. We observed on chromosome 9 a cluster of loci that display an excess of affected sibs sharing allele IBD that encompassed isolated loci reported in Table 1 . This region was delimited by D9S289 and D9S164 with a maximum model-free LOD score value of 2.87 at D9S290 (empirical P-value ¼ 0.002, IBD sharing ¼ 65.7), which dropped to 2.05 under ASMI.
A new region, spanning through markers D1S468 and D1S548, was observed without previous support from parametric analysis. Table 3 lists loci with maximal LOD score values over 1 for the ASP test from ANALYZE package. As previously reported, the region flanked by loci D12S78 and D12S378 contained successive loci with LOD score values greater than 1 (P-value r0.015) or close to this threshold. Moreover, a novel area, ranging from locus D10S589 to locus D10S537, was pointed out. This analysis agreed with results previously reported by sib_ibd for the region around locus D7S517 since a LOD score value over 1 was observed at this locus and P-values of 0.0223 and 0.0491, respectively, were observed at its flanking loci D7S531 and D7S513 under ASMII. Under this ASM, we observed three P-values less than 0.025 in a cluster of four successive loci: D2S142 (P-value ¼ 0.0188), D2S2330 (P-value ¼ 0.0248), D2S326 (P ¼ 0.2018) and D2S364 (P-value ¼ 0.0177). Two adjacent loci, D17S1303 and D17S799, had P-values of 0.039 and 0.041. Both clusters from chromosome 17 reported in the parametric analysis are adjacent to locus D17S1303. We observed a maximal LOD score value close to 2 at locus D20S100 and a P-value of 0.026 at neighbouring locus D20S171. Only one locus from Marker band and its position were obtained from the UCSC genome browser (http://genome.ucsc.edu/). Successive loci with maximum LOD score value 41 are grouped together. Empirical P-values associated to LOD score values were established on the basis of 1000, 5000 and 10 000 simulations, respectively, for score values between 1.00 and 2.00 exclusively, between 2.00 and 3.00 exclusively and, finally, greater or equal to 3.00.
chromosome 5, D5S429, located 20 Mb from D5S673, gave LOD score value greater than 1, but we observed a P-value of 0.035 at the adjacent marker D5S400.
Discussion
We report here results from a second genome-wide scan based on an extended sample of families that included a subset previously used for linkage analysis. 16 This scan used a modified panel of 380 markers, including 233 markers not used in the first study. New results obtained from this study disclose increased evidence for linkage between bipolar affective disorder and the 12q23-q24 region since the parametric LOD score value observed at D12S378 was greater than 3.3, the threshold recommended by Lander and Kruglyak 50 as significant linkage. Another region of interest emerged from chromosome 17 where a suggestive linkage was reported at D17S925. However, we could not confirm support for a susceptibility locus on chromosome 21 that we reported in our previous study. 16 Finally, some regions of lower LOD score values were reported on chromosomes 2, 5, 7, 9, 10 and 20.
The presence of a susceptibility gene in the chromosomal region 12q23-24 and segregating in Saguenay-Lac-St-Jean families had been pointed to by our previous genome scan, 16 and additional families have now permitted confirmation of this result. Since true positive peaks are expected to be broader than false positive peaks, 51 ,52 the presence of a broad region, including at least four successive loci supporting the linkage hypothesis under parametric and model-free analysis, increased our conviction of the presence of a susceptibility locus for bipolar disorder on the long arm of chromosome 12. Additionally, replication results observed throughout this region represent an important way to validate our results (Figure 2 ). Craddock et al 11 described a North Wales family where Darier's disease gene, mapped telomeric to D12S78 53 and now known to be ATP2A2, 54 cosegregates with major affective disorder. Support for the broad Darier's disease region was given by Dawson et al, 12 Detera-Wadleigh et al 9 and Morissette et al, 16 but Jacobsen et al 55 found no evidence for association between the bipolar disorder and the Darier's disease gene. Abkevich et al 18 strongly support the existence of a susceptibility locus for major depression at 12q22-q23.2 with a multipoint heterogeneity LOD score of 6.1 at locus D12S1706. Dawson et al 56 reported a modest association between bipolar disorder susceptibility gene and PLA2 (Pvalue ¼ 0.01), another gene mapped on chromosome 12 distal from 12q23, but Jacobson et al 57 were unable to replicate this finding. Assuming homogeneity, a dominant mode of inheritance and bipolar individuals as affected, Ewald et al 13 reported a LOD score of 3.37 at locus D12S1639 (12q24.31). Subsequent analysis on subjects from the Faroe Islands supported the presence of a susceptibility locus to bipolar disorder in the area between loci D12S1614 and D12S1675, a region that includes D12S1639. 17 The linkage study of Curtis et al 19 using Icelandic and British pedigrees supports linkage findings over the 12q24 chromosomal region with a three-point MAL-OD score of 2.8 at marker D12S342, which is between D12S86 and D12S378. Our strongest results on chromosome 12 are obtained under the ASMII model, suggesting that both BP and UPR have a common genetic base.
Large variations in the localization of genes with small to moderate effects have been shown. 4, 5 This may explain why replication studies reported above spanned throughout our broad region. On the other hand, Ewald et al 13 highlighted the possibility that more than one vulnerability gene for bipolar affective disorder may lie along the long arm of chromosome 12. Indeed, our recent association study 58 supports the SNP and haplotype analysis of Zill et al, 59 which suggested the involvement of the second tryptophan hydroxylase isoform gene (TPH2) in major depression. The TPH2 gene is located about 5.76 Mb centromeric to locus D12S326 (12q21.1) where we obtained a parametric LOD score value of 2.80. On the other hand, the maximal parametric LOD score on chromosome 12 was observed at D12S378 (12q24.31) under a recessive genetic model rather than a dominant one as observed by other groups in this chromosomal region. Although this singular situation could be due to the presence of a different susceptibility gene, it likely results from the advent of recessive and dominant mutations in the same gene. 60 The segregation mode may also be influenced by epistatic or environmental factors. 25 In our preceding publication 16 we identified a branch from the VL pedigree where individuals diagnosed as BP and UPR shared a common haplotype over chromosomes 5 and 21. In the present study, the three markers from chromosome 5 with LOD score values greater than 1 or P-values less than 0.05 were mapped within the qter distal haplotype. Although addition of new families to our sample did not confirm our previous linkage results, we believe that this region should still be considered for further analysis. Suarez et al 3 showed that, in the presence of a vulnerability gene implicated in an oligogenic trait, increasing the sample size may initially decrease LOD score values before reaching a significant threshold. This region was also reported by other groups. 9, 61, 62 Suggestive evidence of linkage at locus D17S925 is also found and supported by six neighbouring loci by parametric and/or model-free approaches. In our previous study, a modest P-value of 0.047 was reported at D17S808, which maps 34 Mb from D17S925. Interestingly, the serotonin transporter, which could be involved in bipolar disorder aetiology, 63 is localized between D17S925 and D17S798. Clearly, further studies are required on this gene before we could infer its involvement in bipolar disorder in the Saguenay-Lac-St-Jean population.
Simulation studies from Goldin and co-workers 64, 65 and Yang et al 66 showed that linkage criteria based on less stringent P-values observed over neighbouring markers could be more powerful than the Lander and Kruglyak criteria 50 applied to a single marker. Under such regional test criteria, we believe that regions described on chromosomes 2, 7, 9, 10 and 20 should be considered for further analysis. Additionally, some of these regions have support from other groups. 33, 35, 67 On the other hand, the importance of the isolated loci D6S264 and DXS1106 with reported suggestive linkage is diminished by the lack of support from flanking markers.
In conclusion, parametric and model-free analysis from this follow-up study confirmed the presence of a susceptibility gene for affective disorder in the chromosomal region 12q23-q24 that segregates in the Saguenay-Lac-St-Jean population. Moreover, this chromosomal area was supported by other independent sources. Linkage disequilibrium mapping will be used to reduce the region of interest for gene identification. For other regions of lower interest, further investigation with larger sample size, additional markers and replication with an independent set of families will be necessary to consider these linkage results as true positives.
